RUNX2 and chronic kidney disease: VSMCs exposed to procalcifying levels of phosphate, akin to what may occur in patients with CKD, lose expression of the smooth muscle contractile proteins SM22α and SM α-actin and express the bone markers Runx2, osteopontin, osteocalcin, and alkaline phosphatase [50].